Survival after reduced-intensity conditioning allogeneic stem cell transplantation (RIC-allo-SCT) for acute myeloid leukemia (AML). (a) Comparison of leukemia-free survival (LFS) between the “donor” (solid line) and “no donor” (dashed line) groups; (b) Comparison of LFS between the “transplant” (solid line) and “no transplant” (dashed line) groups; (c) Comparison of overall survival (OS) between the “transplant” (solid line) and “no transplant” (dashed line) groups; (d) Comparison of OS between the “donor” (solid line) and “no donor” (dashed line) groups. Probabilities of LFS and OS were estimated from the time of diagnosis using the Kaplan-Meier product-limit estimates.
 Reprinted with permisson from Mohty M et al. Leukemia. 2009;23:194-195.²⁰